首页 | 本学科首页   官方微博 | 高级检索  
检索        

陕西省HIV/AIDS患者接受抗病毒治疗后病毒载量结果及其影响因素分析
引用本文:张超,付钰淋,李华,任强,常文辉.陕西省HIV/AIDS患者接受抗病毒治疗后病毒载量结果及其影响因素分析[J].实用预防医学,2019,26(4):397-399.
作者姓名:张超  付钰淋  李华  任强  常文辉
作者单位:陕西省疾病预防控制中心艾滋病预防控制所,陕西 西安 710054
基金项目:陕西省疾病预防控制重大科研课题(2014A5)
摘    要:目的分析陕西省艾滋病病毒(human immunodeficiency virus,HIV)感染者/艾滋病(acquired immune deficiency syndrome,AIDS)患者(以下简称为HIV/AIDS患者)接受抗病毒治疗后病毒载量结果及相关影响因素。方法对接受抗病毒治疗六个月以上的1 046例HIV/AIDS患者进行病毒载量检测,结合病例流行病学资料分析病毒载量结果及其影响因素。结果 1 046例HIV/AIDS患者中,≥1 000 copies/ml占9.6%(100/1 046),50~999 copies/ml占9.1%(95/1 046),<50 copies/ml占25.4%(266/1 046),TND(未检出病毒)占55.9%(585/1 046)。单因素分析显示病毒载量结果<1 000 copies/ml与≥1 000 copies/ml HIV/AIDS患者在民族(P<0.05)、教育程度(χ~2=10.901,P<0.05)、感染途径(χ~2=14.286,P<0.05)变量上差异有统计学意义。多因素分析显示教育程度大专及以上是病毒载量≥1 000 copies/ml的保护因素(OR=0.344,95%CI:0.121~0.979),HIV感染途径中注射吸毒是病毒载量≥1 000 copies/ml的危险因素(OR=5.237,95%CI:1.272~21.556)。结论陕西省HIV/AIDS患者抗病毒治疗效果较好,但需要提高患者治疗依从性,减少病毒抑制失败。

关 键 词:HIV/AIDS患者  病毒载量  抗病毒治疗
收稿时间:2018-07-09

HIV viral load after receiving antiretroviral therapy and its influencing factors in HIV/AIDS patients in Shaanxi Province
ZHANG Chao,FU Yu-lin,LI Hua,REN Qiang,CHANG Wen-hui.HIV viral load after receiving antiretroviral therapy and its influencing factors in HIV/AIDS patients in Shaanxi Province[J].Practical Preventive Medicine,2019,26(4):397-399.
Authors:ZHANG Chao  FU Yu-lin  LI Hua  REN Qiang  CHANG Wen-hui
Institution:Department of AIDS Prevention and Control, Shaanxi Provincial Center for Disease Control and Prevention, Xi’an, Shaanxi 710054, China
Abstract:Objective To analyze the results of HIV viral load after receiving antiretroviral therapy and related influencing factors in HIV infectors/AIDS patients (hereinafter to be referred as HIV/AIDS patients) in Shaanxi Province. Methods The viral load of HIV was detected in 1,046 HIV/AIDS patients who underwent antiretroviral therapy for more than six months, and the viral load results and related influencing factors were analyzed combined with their epidemiological data. Results Among the 1,046 HIV/AIDS patients, patients with HIV viral load ≥ 1,000 copies/ml, 50-999 copies/ml and <50 copies/ml and patients reported as TND (target not detected) accounted for 9.6% (100/1,046), 9.1% (95/1,046), 25.4% (266/1,046) and 55.9% (585/1,046) respectively. Univariate analysis showed that there were statistically significant differences in the ethnic group (P<0.05), educational background (χ2=10.901, P<0.05), route of infection (χ2=14.286, P<0.05) between the group of HIV viral load < 1,000 copies/ml and the group of HIV viral load ≥ 1,000 copies/ml. Multivariate logistic regression analysis showed that college and above educational background was the protective factor for viral load ≥ 1,000 copies/ml (OR=0.344, 95%CI:0.121-0.979), while injection drug use was the risk factor for viral load ≥1,000 copies/ml (OR=5.237, 95%CI:1.272-21.556). Conclusions Antiretroviral therapy for HIV/AIDS patients in Shaanxi Province is characterized with good clinical effect, but it is still necessary to improve the patients’ treatment compliance and reduce the virus suppression failure.
Keywords:HIV/AIDS patients  viral load  antiretroviral therapy  
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《实用预防医学》浏览原始摘要信息
点击此处可从《实用预防医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号